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Signal Amplification by Reversible Exchange (SABRE): From
Discovery to Diagnosis
Peter J. Rayner[a] and Simon B. Duckett*[a]
Abstract: Signal Amplification by Reversible Exchange (SABRE)
turns typically weak magnetic resonance responses into strong
signals making previously impractical measurements possible. This
technique has gained significant popularity due to its speed and
simplicity. This minireview tracks the development of SABRE from
the initial hyperpolarization of pyridine in 2009, to the point where
50% 1H polarization levels have be achieved in a di-deuterio-
nicotinate, a key step in the pathway to potential clinical use. Simple
routes to highly efficient 15N hyperpolarization and the creation of
hyperpolarized long-lived magnetic states are illustrated. It finishes
by describing how the recently reported SABRE-RELAY approach
offers a route for parahydrogen to hyperpolarize a much wider array
of molecular scaffolds, such as amides, alcohols, carboxylic acids
and phosphates, than was previously thought possible. We predict
that collectively these developments ensure that SABRE will
significantly impact on both chemical analysis and the diagnosis of
disease in the future.
1. Introduction
Nuclear Magnetic Resonance (NMR) and Magnetic
Resonance Imaging (MRI) are now ubiquitous techniques that
are used in the study of molecules and materials despite an
inherent insensitivity. Classically, the small Boltzmann derived
spin energy level population difference is overcome through the
use of large magnetic fields, increased sample concentrations
and extended signal averaging. However, these approaches
have both time and cost implications, and for this reason,
essentially all current clinical MRI applications make use of a
water signal due to its high in vivo concentration. Thus,
hyperpolarization methods that create a non-Boltzmann
population distribution of magnetic spins are highly desirable
and have now begun to influence biomedical imaging and
disease diagnosis.[1] Spin Exchange Optical Pumping (SEOP)
and Dynamic Nuclear Hyperpolarization (DNP) are two of the
most clinically developed approaches, having been successfully
used for the study of lung physiology and prostate cancer
metabolomics respectively.[1c, 1d, 2] Hence, hyperpolarized MRI is
predicted to play a growing role in human health.[1a, 3]
In addition, given the widespread use of NMR for the
characterization of materials in solution, hyperpolarization also
opens up potential routes for analysis where only small amounts
of analyte are available.[4] Such methods are likely to be of great
importance for the detection and identification of trace impurities
in the pharmaceutical pipeline. Furthermore, the identification of
transient reaction intermediates involved in catalytic processes
reflect a further area where hyperpolarization studies might be
expected to aid the improvement of reaction outcomes and thus,
reduce the environmental impact of industrial processes.[5]
An alternative and simple route to nuclear spin
polarization involves the addition of singlet state based para-
hydrogen (p-H2) to an unsaturated center, collectively termed
ParaHydrogen Induced Polarization (PHIP).[6] The potential
clinical uptake of PHIP techniques have been hindered by the
need for chemical change - commonly hydrogenation of organic
molecules such as alkynes and alkenes – which limits the range
of suitable substrates.[7] Recently, the use of cleavable,
unsaturated molecular tags, including propargyl esters, has
broadened the scope of the PHIP method to include access to
pyruvate, acetate and even lactate for the monitoring of
metabolism in vitro.[8]
In 2009, the PHIP technique termed Signal Amplification
by Reversible Exchange (SABRE) allowed access to
hyperpolarized substrates without changing their chemical
identity.[9] While SABRE releases the latent polarization in p-H2
by binding it to a metal catalyst, the concurrent binding of a
substrate molecule allows it to become hyperpolarized by
transfer through the scalar coupling network[7, 10] and
dissociation allows the build-up of polarized substrate in solution
by the cycling of the steps as depicted in Scheme 1. We set out
here to show how SABRE reflects a rapid and efficient route to
hyperpolarization that we predict will impact favorably on many
areas of science in the future.
Scheme 1. Schematic representation for the SABRE catalytic cycle in which
p-H2 hyperpolarizes a target substrate (sub).
2. Development of SABRE Catalysis
SABRE is a catalytic process where in the transfer of latent
magnetization from p-H2 proceeds to a target substrate. To
achieve this effect, a metal center acts as a scaffold to
temporarily bring together the substrate and p-H2 in the form of
hydride ligands. At low magnetic field, polarization is
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spontaneously transferred through the scalar coupling
network,[10-11] though in-high-field transfer using radio frequency
(r.f.) methods have also been applied.[12] A number of
theoretical descriptions[7, 9-11, 13] for the SABRE technique have
been reported.
2.1. Theoretical Descriptions of SABRE
The SABRE phenomenon was originally described using a
density matrix theory approach based on a model four-spin
system derived from two spins which originate in p-H2 and two
that originate in the bound substrate.[10] The low field evolution of
the polarization as a function of magnetic field was modelled and
the effect of transport into the magnet considered. The analytical
solution predicts that scalar coupling in the SABRE catalyst
results in the transfer of spin order between the p-H2 derived
hydride ligands and the two additional bound nuclei. These
nuclei were found to retain enhanced populations of visible
longitudinal single spin (the normal Zeeman polarization) and
two-spin order terms after substrate dissociation. However, the
associated zero quantum terms were stated to reflect the
creation of singlet states that would be preserved in ultra-low
field. Unfortunately, while being accurate, this model’s reliability
depends critically on several very small J-couplings that are hard
to measure.
A complementary method based on level anti-crossings
(LACs) yields analogous but more qualitative results, whilst
providing a much clearer and intuitive picture of the origin of
SABRE polarization.[11, 13a] A LAC arises at a magnetic field
where two energy levels would cross in the absence of spin-spin
coupling. For SABRE, efficient mixing of the corresponding
substrate and p-H2 derived spin-states therefore occurs when
substrate and hydride resonance frequency differences match
the difference between the mutual hydride spin couplings and
the sum of one quarter of their mutual couplings to substrate.[13c]
Hence spin order transfer efficiency depends explicitly on the
scalar coupling network within the catalyst and the magnetic
field experienced at the point of polarization transfer. Thus, this
method has the benefit of enabling the rapid prediction of the
optimum magnetization transfer field for a particular substrate.
However, as SABRE is a dynamic process, the effect of
chemical exchange of p-H2 and the substrate at the catalyst
need to be considered. Furthermore, spin state relaxation during
this process tempers the build-up of SABRE derived polarization
in solution. An analytical model that combines kinetics and
nuclear spin evolution has been presented which addresses
these concerns.[13b] This model predicted that optimal SABRE
transfer, in the low field regime, occurs when the rate constant
for substrate dissociation is on the order of the spin mixing
frequency at a LAC. Conversely, the substrate dissociation rates
should be as fast as possible for high field SABRE. Additionally,
the relative concentrations of p-H2, substrate and catalyst are
important, with large signal enhancements resulting for low
substrate-to-catalyst ratios and high p-H2-to-catalyst ratios. The
authors conclude that relaxation within the active catalyst can
inhibit efficient polarization build up.
Both the steady-state and dynamic behavior of the SABRE
process have been considered using a strategy that takes into
account spin-evolution in the catalyst and substrate
exchange.[13c] This method allows for multi-spin systems, time
dependent SABRE polarization and polarization formed through
r.f irradiation. This report also includes a comparison of the
theoretical descriptions of the SABRE effect.
Overall, the reported theoretical descriptions allow us to
define the key components needed for optimal SABRE catalysis;
the lifetime of the active SABRE catalyst must be on the
appropriate timescale for efficient polarization transfer; the size
of the spin-spin coupling between the p-H2 derived hydride
ligands themselves and the NMR active nuclei in the substrate
must be large relative to the timescale of relaxation; the
polarization transfer field (PTF) at which the catalysis is
undertaken must reflect the matching condition associated with
optimal transfer. These factors have been explored and
harnessed through an array of experimental studies whose
chronology can predate these theoretical predications.
2.2. Ancillary ligand effects on SABRE complex lifetime
In fact the reversible binding of the substrate and p-H2 to
the metal complex were found experimentally to be crucial to
efficacious SABRE. If these binding interactions are too strong,
and become irreversible, then efficient polarization is
suppressed as the necessary p-H2 addition is stopped. Likewise,
if these interactions are too weak, then the active SABRE
catalyst can become unstable leading to rapid depletion of p-
H2,[14] inefficient polarization transfer[13c] or, at worst, the catalysts
decomposition. As such the development of metal complexes
that mediate reversible exchange on an appropriate timescale
has received much attention.
The initial SABRE observations utilized the pre-catalyst
[Ir(COD)(PCy3)(py)]BF4 (where COD = cis,cis-1,5-cyclooctadiene,
Cy = cyclohexane and py = pyridine) to mediate polarization
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transfer.[9] The active complex in this case is formed by the
oxidative addition of H2 in the presence of excess pyridine to
give [Ir(H)2(PCy3)(py)3]BF4. The small scalar couplings between
the hydride ligand and ortho-pyridine protons[15] were sufficient
to allow spontaneous magnetization transfer to take place at low
magnetic field.[16] It was rapidly realized that the identity of the
phosphine ligand played an important role, with the
corresponding PCy2Ph derived catalyst proving to be far
superior.[16] This improvement was due to the fact that the steric
bulk of the phosphine promoted substrate loss whilst its strong
electron donating properties promoted H2 exchange.
It was the discovery that by replacing the phosphine ligand
with an N-Heterocyclic Carbene (NHC) which unlocked the large
polarization levels that are now associated with SABRE.[17] In
fact, the air stable pre-catalyst [IrCl(COD)(IMes)] (where IMes =
1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidine) resulted in
~8.1% polarization for pyridine compared with 2.5% for the
phosphine catalyst. This improvement was found to be
associated with the increased rate of pyridine dissociation from
the active catalyst [Ir(H)2(IMes)(py)3]Cl and the promotion of H2
exchange. Exchange Spectroscopy (EXSY) was used to
quantify the rate constant for pyridine dissociation in
[Ir(H)2(IMes)(py)3]Cl as 23 s-1,[18] which is significantly faster than
that of the phosphine derived catalyst [Ir(H)2(PCy3)(py)3]Cl which
had a pyridine dissociation rate constant of just 0.45 s-1.[16]
Substrate dissociation is vital to the ‘refreshing’ of p-H2
within SABRE catalysis as shown in Scheme 1. In the case of
IMes derived catalysts, this leads to the transient formation of
[Ir(H)2(Ș2-H2)(IMes)(py)2]Cl which can rearrange to expel H2 and
bind the substrate in either an associative or dissociative manor
to complete the catalytic cycle. Density Functional Theory (DFT)
has been used to confirm these proposed intermediates.[17]
The identity of the NHC ligand can also be modified to vary
the lifetime of the active complex. For example, the sterically
bulky SIMes or IPr ligands of Figure 1 yield increased rates of
pyridine dissociation as a consequence of the change
in %Vbur.[18] Despite over 10 commercially available NHC
ligands used for the SABRE polarization of pyridine,[18-19] to date
[IrCl(COD)(IMes)] remains the most impressive mediator of
polarization transfer. This optimum activity is common across a
range of heterocyclic motifs although rare examples exist where
this is not the case.[20]
Thus far, no quantifiable correlation between the steric and
electronic properties of the NHC ligands and polarization levels
has been established; however aromatic NHC ligands typically
show improved performance.[19] This reflects the complexity of
WKH 6$%5( WUDQVIHU VWHS DOWKRXJK UHFHQWO\ WKH ʌDFFHSWLQJ
ability parameter[21] has been shown to offer better insight into
how the NHC ligand influences the rate of pyridine exchange.[22]
Figure 1. Structures of NHC ligands used for SABRE catalysis.
Other SABRE catalysts have been shown to undergo such
non-hydrogenative transfer of polarization including the
bidentate NHC-phenolate (1),[23] an iridium PNP-pincer (2)[14] and
an iridium cyclooctene complex (3)[24] shown in Figure 2,
however signal gains were reduced when compared to
[IrCl(COD)(IMes)].
Figure 2. Structures of alternative ligands used for SABRE catalysts
In summary, catalyst identity is critical for efficient SABRE
and can be used to control the polarization outcome. Looking
forward, it may be possible to further modulate the complex
lifetimes through ligand development which could be the key to
expanding the substrate range amenable to the SABRE method.
2.3. Effect of polarization transfer field on SABRE catalysis
The magnetic field at which SABRE catalysis is conducted
has been shown to determine the magnitude of substrate
polarization. For SABRE transfer to 1H nuclei, the magnetic field
at which maximum polarization transfer is observed is caused by
the LAC point as determined by the hydride-hydride scalar
coupling in the active SABRE catalyst[11] or by optimal spin
evolution within the density matrix model.[10] Both theoretical
approaches provided comparable conclusions. The hydride-
substrate coupling then allows polarization to transfer and
Tessari et al. have shown experimentally that a typical 4JHH
coupling is ~1.2 Hz (Figure 3.).[15] As such, for transfer to 1H-
nuclei, optimal polarization transfer is usually observed in the
~5-8 mT range[17, 25] and the PTF can be accurately controlled
using an automated flow system.[26]
Polarization can also be transferred to heteronuclei bound
directly to the catalyst via a 2JHX scalar coupling. This refinement
has been exemplified for both 15N[27] and 31P[28] hyperpolarization.
When a 2JHX scalar coupling is used, the optimum transfer field
FDQ QRZ EH LQ WKH UHJLRQ RI a ȝ7 ZKLFK LV DFKLHYHG E\
FRQGXFWLQJ WKH6$%5(FDWDO\VLV LQVLGHDȝPDJQHWLFVKLHOG[27a]
This protocol has been termed “SABRE-SHEATH” (Signal
Amplification by Reversible Exchange-in SHield Enables
Alignment Transfer to Heteronuclei) and its scope is discussed
in detail later.
A drawback of conducting the SABRE polarization transfer
in low magnetic fields is the requirement for fast transfer into
high field where detection takes place. Alternate approaches use
radio frequency (r.f.) methods to drive polarization transfer at
high field. Thus, immediate detection and recycling is possible
which provides a simple route to rapid repetitive measurements.
High-field SABRE was used in 2009 when p-H2 derived
magnetization was transferred to pyridine-15N using an INEPT
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based procedure.[12a] Methods to transfer polarization have since
been developed that fulfil the LAC demands of SABRE through
r.f. excitation.[12b, 29] This route has been applied to a range of
substrates and 1H signal enhancements of ca. 360-fold at 9.4 T
have been achieved. Recently, the Alternating Delays Achieve
Polarization Transfer (ADAPT)[30] sequence has been applied to
to SABRE to give a 15N signal gain of nearly 1000-fold at 11.7 T
in just 1.6s.[31]
Alternatively, high-field transfer can be achieved using low-
power continuous-wave pulses, in the LIGHT-SABRE (Low
Irradiation Generation of High Tesla-SABRE) method.[12c] This
approach has been used with 15N-labelled pyridine and yielded
15N signal enhancements of ca. 480-fold at 9.4 T. interestingly,
as large resonance frequency differences can be overcome
LIGHT-SABRE is applicable to any coupled pair of nuclei.
2.4. Use of a co-ligand in SABRE catalysis
As discussed, in order for p-H2 to be harnessed its
symmetry must be broken. High symmetry SABRE catalysts of
the type [Ir(H)2(IMes)(substrate)3]+ actually rely upon magnetic
inequivalence for polarization transfer. However, by adding a co-
ligand it is possible to form complexes of type
[Ir(H)2(IMes)(substrate)2(co-ligand)]+. In this scenario,
polarization transfer results from both coupling and chemical
asymmetry.. As the strength of the hydride-hydride and hydride-
substrate couplings and catalyst lifetimes can be changed by
varying the complex, tunable hyperpolarization efficiency results
from both situations, although, in the latter case, transfer into the
axial ligands is therefore possible. A number of examples have
utilized an equatorially bound co-ligand, such as acetonitrile, to
break the chemical symmetry of the SABRE active catalysis.[20,
23b, 32] In this case both acetonitrile and the target substrate are
hyperpolarized. An alternative approach utilized a fully
deuterated isotopologue of the targeted SABRE substrate as a
co-ligand.[25, 32-33] Here, the co-ligand does not receive visible
polarization itself and has the effect of focusing the polarization
into the 1H-sites on the target substrate. This method has
yielded almost double the polarization level that could be
achieved in the absence of the co-ligand.
A co-ligand is also required for substrates whose binding is
too weak to stabilize the active catalyst or when a
substoichiometic amount of substrate is present.[4e, 34] A
common co-ligand in these situations is 1-methyl-1,2,3-triazole,
as it has a higher affinity for binding to the complex than the
solvent, has favorable lifetimes for SABRE and it’s 1H NMR
signals do not overlap with those of the substrates that were
studied.
2.5. Effect of the catalyst on relaxation rates
The rate of relaxation of the SABRE induced
magnetization is also important if it is to survive to the site of a
delayed measurement. It has been consistently shown across a
range of substrates that, in the presence of the SABRE catalyst
and H2, the effective T1 value of free substrate decreases.[18, 33]
The measured T1 values of the free substrate is therefore a
weighted average of the material in bulk solution and that bound
to the catalyst due to the reversible exchange process.[13b] By
cooling the SABRE reaction to 263 K, ligand dissociation can be
quenched, allowing relaxation rates for the substrate whilst
bound to the catalyst to be measured. T1 relaxation times of 0.5-
2 s were observed for methyl 4,6-d2-nicotinate which is a
dramatic reduction of the T1 value of the free material which is
over 1 minute.[33]
In order to reduce this effect a number of approaches have
been taken. First, by increasing the substrate concentration
relative to the catalyst the equilibrium contributions of the free
and bound substrate change and thus, the effective T1 values
increase.[18] However, this typically also leads to reduced
enhancement values being observed. Alternatively, deuterium
labelling of the NHC ligand has been shown to increase the
lifetime of substrate polarization whilst bound to the metal
center[20, 23b, 33, 35] and has led to the observed 1H-polarization
levels increasing by ~150% in methyl 4,6-d2-nicotinate. This
isotopomeric NHC ligand may also have the dual effect of not
being able to receive polarization itself, and thus removes a
further possibility for spin-dilution. A final option to extend the
substrate relaxation time is through the addition of a chelating
ligand, such as phenanothroline, after the SABRE polarization is
complete. This process quenches the active SABRE catalyst
thereby preventing the reversible exchange of the substrate and
returns its T1 values to normal which allows detectable
polarization to remain visible for a longer time period.[36]
However, this approach does not allow for re-hyperpolarization.
3. 1H-SABRE Polarization
SABRE induced polarization of 1H-nuclei is by far the most
extensively studied to date due to the very high natural
abundance, high gyromagnetic ratio and ubiquity in a range of
naturally occurring and drug molecules. It also has the benefit of
being directly observable on any existing hospital scanner which
may lead to facile clinical translation.
3.1. Scope of 1H SABRE Polarization
Typically Lewis basic nitrogen containing molecules such
as N-heterocycles and nitriles[32] are most effective for 1H-
SABRE polarization although there are also a few successful
examples of polarization transfer to sulfur heterocycles.[37]
Substituted pyridyl substrates have proved to be particularly
efficacious to SABRE and 1H polarization levels of up to 50%
have been reported.[33] More complex substrates have also been
shown to be amenable to SABRE with molecules with multiple
ligation modes[20, 38] and a number of biologically significant
molecules such as nicotinamide,[33] vitamin B3,[39] adenosine[40]
and the tuberculosis drug, isoniazid showing good signal
gains.[35, 41] It has also been shown that polarization efficiency is
decreased if no 4JHH coupling is present in the active catalyst
and a smaller 5/6JHH coupling has to be utilized instead.[33] These
couplings are depicted in Figure 3 for the model catalyst
[Ir(H)2(IMes)(py)3]+.
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Figure 3. Representation of the scalar couplings between the hydride ligand
and protons in the substrate molecule for [Ir(H)2(IMes)(py)3]Cl.
3.2. Effect of selective deuteration on substrate polarization
and relaxation rate
A well-established route to improve the efficacy of
hyperpolarization techniques is the use of selective deuteration
of the substrate.[42] When applied to the SABRE technique,
3,4,5-d3-pyridine showed improved performance over its protio
analogue.[17, 43] A detailed study that probed the optimal
deuteration pattern has been reported for nicotinamide and
methyl nicotinate.[33] Placement a proton ortho to the nitrogen
binding site was shown to be optimal for efficient polarization
transfer but coupling to a remote proton was optimal for a long
magnetic state lifetime. These structures are shown in Figure 4
and have up to 5 times greater T1 values and delivers 4-fold
improvement in polarization level. Similar improvements have
now also been reported for the Tuberculosis drug isoniazid and
its derivatives.[35]
Figure 4. Comparison T1 and polarization values for methyl nicotinate and its
optimally deuterated isotopologue with their 1H NMR thermal (top, x64
expansion) and hyperpolarized (bottom) spectra.
3.2. SABRE derived 1H-singlet states
SABRE harnesses the long lived single state of p-H2 as its
source of polarization. In this context, singlet states are non-
magnetic spin isomers of a coupled spin-1/2 pair which are
immune to external dipolar coupling. It is therefore possible to
identify other molecules where two almost identical protons exist
in a single state as detailed by Levitt.[44] The SABRE technique
can hyperpolarize such states, as was exemplified for the
strongly coupled 1H-pair in 2-aminothiazole[45] where the singlet
state was accessed in 90% efficiency by rf-methods and using a
spin-lock as pioneered by Levitt.[44] This approach has also been
applied to derivatives of nicotinamide and pyrazinamide that
have isolated spin-pairs through selective deuteration.[46]
The current state of the art utilizes a pyridazine based 1H-
VSLQSDLU WKDWH[KLELWDǻį of only 1 Hz despite having a strong
3JHH coupling.[47] As a consequence the state lifetime was
observed to be over 4 minutes at low field and a SABRE
hyperpolarized signal could still be observed 15 minutes after
polarization transfer. This method shows great potential for
progression towards clinical applications as the polarization can
be stored in long live singlet state prior to injection and then
subsequently observed in vivo.
4. 15N-SABRE Polarization
Hyperpolarization of 15N-nuclei offers an interesting
alternative to 1H-nuclei due to their relaxation times being
typically longer. An area of rapid development over the past five
years has been the direct polarization transfer to 151DW ORZȝ7
magnetic fields.[48] This SABRE-SHEATH method exploits the
strong 2J-coupling between the hydride ligands and a 15N donor
atom in the active catalyst.[27a]
4.1. Scope of 15N-SABRE Polarization
The SABRE-SHEATH method has polarized a broad range
of substrates that include N-heterocycles,[27b, 49] nitriles,[49a] Schiff
bases,[50] diazene[49a] and diazirines.[34, 51] The antibiotic
metronidazole has also been polarized with levels of over 20%
and may lead to assessment of its in vivo fate.[52] 15N-SABRE
induced polarization has also been observed using permanent 1
T magnets[49a] and makes possible the polarization of neat
liquids.[53]
5.2. 15N2 Diazirines as Molecular Imagining Tags
More recently, SABRE has been applied to the
hyperpolarization of 15N2 diazirines, shown in Figure 5, which
can be used as biocompatible molecular tags without
significantly modulating biological function.[51] Interestingly, the
type of polarization that was created can be selected simply by
changing the magnetic field at which the SABRE process occurs.
As such, polarization transfer at ca. 6 mG gave Z-magnetization
(triplet state) with up to 5% polarization and a decay constant of
ca. 6 min. Alternatively, the singlet state can be populated at
almost any magnetic field because the coupling between the
hydrides of the active catalyst, and the coupling between the
15N2-diazirine are almost equal (JHH = 10 Hz, JNN = 17.3 Hz).
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6$%5( LQGXFHG VLQJOHW SRODUL]DWLRQ RI §  ZLWK D GHFD\
constant of 23 min was observed at 120 G.
Figure 5. Structure of diazirines polarized using SABRE
The original reported diazirine contained two sites for
potential ligation; the diazirine and nitrile functionalities.
However, this has been shown to be unnecessary for efficacious
15N2 polarization transfer.[34] Instead, addition of a Lewis basic
additive (e.g. pyridine, MeCN, D2O) sufficiently stabilizes the
SABRE catalyst to give monodentate diazirine species. This
important breakthrough may open the door to the use of
diazirine tags for bimolecular imaging or a wide range of
biological relevant targets in the future.
5. Polarization of Other Heteronuclei
5.1. 13C-SABRE hyperpolarization
The hyperpolarization of 13C nuclei has been the
predominant choice for in vivo DNP studies due to its greater
natural abundance than 15N and typically long relaxation times.[1c,
1d, 54] However, the development of 13C-SABRE has been
hindered in part due to low polarization levels. When SABRE
was employed for the polarization of nicotinamide at natural
abundance, all six 13C resonances were visible[26] whilst when
the nicotinamide carbonyl was isotopically enriched a 65-fold
enhancement at 9.4 T has been reported.[43] In 2015 Truong et
al. probed the feasibility of transfer of SABRE-SHEATH induced
polarization of 13C in pyridine-15N however enhancements were
less than 10-fold at 9.4 T.[27b] More recently the
hyperpolarization of pyridine-15N was revisited and 13C-
polarization levels of ca. 4.4% were reported.[55] These
improvements in SABRE efficiency are due to the utilization a µT
polarization transfer field and optimization of temperature and
concentration. Interestingly the 13C-polarization observed in
pyridine-14N was significantly lower than its 15N isotopologue.
The authors concluded that this was due to significant
quadrupolar 14N-relaxation in the µT fields used during the study,
which may inform the design of SABRE contrast agents in the
future.
SABRE induced polarization of 13C nuclei has also been
stored in long lived states which have been accessed in a series
of substituted pyridazines via either the breaking of their
magnetic or chemical symmetry by synthetic design.[56] When
magnetic inequivalence, due to the distinct scalar couplings
EHWZHHQ WKH FDUERQ DQG SURWRQ QXFOHL ZDV XWLOL]HG D §
polarization level was observed in conjunction with a singlet
lifetime of nearly 2 minutes at low field. It is likely that the
polarization is transferred both directly and via the vicinal 1H-
nuclei as when they are replaced with deuterium the polarization
GURSSHG WR §  :KHQ FKHPLFDO LQHTXLYDOHQFH LV XVHG WR
access the singlet state by introduction of a CD3 group to the
phenyl ring, the singlet state lifetime was extended to over 3
PLQXWHV WKRXJK WKH SRODUL]DWLRQ ZDV UHGXFHG WR §  7KLV
allowed a signal to be observed over 10 minutes after the
SABRE catalysis was conducted. Functionalized acetylenes
have been polarized under SABRE-SHEATH conditions to give
up to 0.12% polarization at 8.5 T in conjunction with signal
lifetimes of up to ~1.95 minutes at 0.3 mT. [57] This report utilizes
the direct hydride-13C couplings found in the active catalyst and
multiple binding modes were found to be possible.
5.2 31P-SABRE Hyperpolarization
Polarization transfer to 31P nuclei was initially seen when they
feature as ligands on the SABRE catalyst and hence exhibit a
direct coupling to p-H2 derived hydride ligands.[23b] However, due
to the strength of Ir-P bonds, reversible exchange did not occur
at room temperature. In order to induce SABRE polarization into
the phosphine ligands, Zhivonitko et al. heated a solution of
(PPh3)3Ir(H)2Cl in toluene to 60 °C. Bubbling p-H2 through the
VROXWLRQ LQDȝ7PDJQHWLF ILHOGJDYHDIROGHQKDQFHPHQW
at 7 T.[28] This could be further improved by heating the solution
to 80 °C where a 260-fold enhancement was now observed due
to improved kinetic parameters. Hyperpolarized 31P images of a
phantom were also recorded under these conditions.
SABRE induced hyperpolarization of 31P nuclei was also
shown for a range of phosphorus substituted N-heterocycles
where up to a 3588-fold enhancement at 9.4 T resulted.[58] This
example involved indirect transfer to 31P via 1H nuclei on the
pyridyl ring with the optimum PTF being 45 G and could be
conducted at room temperature. This technique allowed for the
polarization of a phosphine, a phosphine oxide, a phosphine
sulfide and a phosphonate ester.
As a multitude of transition metal catalysts contain
phosphine derived ligands, these techniques may open to door
to NMR monitoring of low concentration reactive intermediates
that may not be visible under standard NMR conditions.
5.3 19F-SABRE Hyperpolarization
The SABRE induced hyperpolarization of 19F nuclei was
initially reported for 3-fluoropyridine in 2009 though
enhancement factors were not quoted.[9] More recently the
polarization of 3-fluoropyridine was revisited with a view to
developing 19F molecular imaging probes.[59] Here, polarization
OHYHOV RI XS WR §  IROG HQKDQFHPHQW DW  7 ZHUH
observed. On addition of concentrated HCl(aq) to the solution, a
10 ppm 19F chemical shift difference was reported, however, the
enhancement was reduced to 13-fold due to extended sample
handling times. Despite potential benefits for biomedical
translation of 19F molecular imaging, such as using the 1H-
channel on existing hospital MRI scanners and no biological
background signal, the 19F nucleus in 3-fluoropyridine has a T1
value of just 10.3 s at 9.4 T and therefore perhaps precludes its
use for in vivo imaging techniques. This highlights the need for
the development of novel 19F contrast agents with extended
lifetimes.
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5.4 29Si and 119Sn-SABRE Hyperpolarization
29Si and 119Sn have also been shown to polarize by
reversible exchange with p-H2.[60] This approach again used
relayed polarization from adjacent 1H nuclei with optimal transfer
occurring at 20 G to give over 200- and 700-fold signal gains at
11.7 T for 29Si and 119Sn respectively. As silyl and stannyl
reagents play a prominent role in synthetic chemistry, typically
as protecting groups or coupling partners, this opens the door to
monitoring and identifying transient intermediates by NMR
spectroscopy during chemical transformations.
6 Analytical Applications of SABRE
SABRE has found a wealth of applications in analytic
sciences, whereby the improved signal strength allows for
previously impractical measurements to be made in seconds. It
is particularly advantageous for investigating analytes that are in
low concentrations in solution.[4e, 61] For example, a solution
FRQWDLQLQJ MXVW  ȝPRO RI TXLQROLQH ZDV K\SHUSRODUL]HG XVLQJ
SABRE in an automated flow system which allowed for the
collection of 13C, 1H and NOE data in addition to the 2D
techniques, COSY AND HMBC.[61] SABRE can also be used to
acquire 2D spectra utilizing FAST-NMR methods.[62] This has
led to ultrafast COSY being recorded in under 1 s.[4a]
A limitation of low concentration measurements is that the
active SABRE catalyst typically requires three substrate
molecules to bind to the iridium center. Therefore, at
substoichiometric amounts of substrate, the SABRE effect is
prohibited. To overcome this, it is possible to use 1-methyl-
1,2,3-triazole as a co-ligand to stabilize the catalyst.[4e]
Importantly, it was noted that at substoichiometric substrate
levels there was a linear relationship between substrate
concentration and signal enhancement. This phenomenon has
been exploited for the quantitative analysis of complex mixtures
in single scan SABRE polarized 1H NMR spectra.[63] These
techniques have been applied to the study of analytes within
biofluids[4d] and could allow for wider detection of drug
metabolites in urine samples in the future. Low concentration
analytes have also been detected by utilizing continuous SABRE
hyperpolarization at high magnetic fields.[4f] More recently, Reile
et al. have described the resolution of 6 dilute analytes by
SABRE hyperpolarization coupled with Diffusion Ordered
Spectroscopy (DOSY).[64]
7. Development of SABRE catalysis towards
in vivo applications
7.1. SABRE catalysis in aqueous solutions
The majority of SABRE polarization studies have been
conducted in methanol-d4 or ethanol-d6 solution however some
examples using other organic solvents are reported.[23a, 41] Whilst,
the biocompatible ethanol-d6:D2O is suitable for SABRE
polarization,[43] T1 relaxation values decrease in solvent mixtures
when compared to the neat solutions.[33] Direct SABRE
polarization in pure water is therefore desired, however the poor
solubility of [IrCl(COD)(IMes)] in aqueous media needs to be
overcome in order to achieve this goal.
One such method is to form the active SABRE catalyst by
reaction with p-H2 and a substrate in an organic solvent as this
chemical change leads to improved aqueous solubility. Zeng
and co-workers achieved this by activating the metal complex in
methanol and subsequently added water to the sample prior to
removal of methanol in a 40 °C water bath.[65] This method
delivered 1% 1H-polarization for 3-amino-1,2,4-triazine, however
analysis of the final solvent composition revealed up to 10%
residual methanol. A similar strategy has been reported whereby
the catalyst was activated in ethanol-d6 and the solvent removed
before the addition of D2O.[66] Again, this chemical change
renders the active catalyst water soluble and led to SABRE
induced 1+VLJQDO HQKDQFHPHQWV RI §IROG LQ QLFRWLQDPLGH DW
9.4 T.
To avoid the pre-activation in an organic solvent, water-
soluble SABRE catalysts were developed as shown in Figures 6
and 7. Firstly, the use of an ancillary phosphine ligand that is
functionalized with hydrophilic arylsulfonates (4) led to aqueous
solubility.[67] Another approach introduced a diol moiety to the
COD ligand (5) allows the pre-catalyst to be dissolved in water
and, despite the removal of this group during the activation
process, the activated SABRE catalyst remains in aqueous
solution.[68] This gave up to 32-fold 1H-enhancments for pyridine
at 9.4 T.
Figure 6. Structure of water soluble SABRE catalysts containing co-ligands
Alternative strategies have concentrated on modification of
the NHC ligand, whereby the introduction of a pendant choline
moiety (6)[67] or using PEGylated groups renders the precatalyst
water soluble.[68-69] The pre-catalyst [IrCl(COD)(IDEG)] (7)
showed most promise and gave up to 42-fold 1H-enhancement
at 7 T DFURVV D QXPEHU RI VXEVWUDWHV DQG §IROG 15N-
enhancement at (7 T) for 15N-pyridine, however, catalyst removal
would still be necessary to create a biocompatible bolus for in
vivo injection.[70]
Figure 7. Structure of water soluble NHC ligands used for SABRE catalysis
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7.2. Heterogeneous SABRE
Heterogeneous SABRE also reflects a potential route to
create a biocompatible bolus as the catalyst could be easily
removed. Heterogeneous catalysis has been widely applied in
PHIP and DNP methods previously.[71] For SABRE, the
immobilized iridium-NHC catalyst on micropolymer beads (8)
JDYH §IROG 1H-enhancment at 9.4 T for the ortho- protons of
pyridine using SABRE (Figure 8).[72] This enhancement, despite
being low, was shown to be achieved only from the
heterogeneous catalysis by comparison to control experiments
on the supernatant solution. Alternatively, an iridium-NHC
catalyst immobilized on silica gel (9) led to a 100-fold 15N-
enhancement at 9.4 T in 15N-pyridine after polarization transfer
at low magnetic fields in methanol.[73]
Currently, neither heterogeneous SABRE nor aqueous
SABRE deliver polarization levels that are commensurate with
biomedical imaging. Additionally, the heterogeneous catalysis
has only been reported in methanol solutions which are not
biocompatible and thus, further development is required before
this high potential technique can be realized for in vivo
applications.
Figure 8. Heterogeneous SABRE catalysts
7.3. Biphasic SABRE catalysis
A facile route to produce a potentially biocompatible bolus
for in vivo investigation has been reported through the use of
biphasic catalysis. This allows the catalyst to remain in the
organic phase and the aqueous phase, containing the
hyperpolarized substrate, can be separated as previously
established for PHIP.[8, 71f] Biphasic SABRE catalysis, dubbed
CAtalyst Separated Hyperpolarization via Signal Amplification by
Reversible Exchange (CASH-SABRE), has been exemplified
using 0.3 mL of CDCl3 containing 5 mM of [IrCl(COD)(IMes)] and
0.3 mL of D2O containing 20-100 mM of the hyperpolarization
target and 0.16 w/v% NaCl.[74] This led to up to 3000-fold signal
enhancement at 9.4 T when using methyl 4,6-d2-nicotinate.
Importantly, just 1.5 x 10-6 M of the iridium catalyst and 0.06%
CDCl3 contamination in the aqueous phase was observed. This
method has been exemplified with a number of substrates and
images showing the hyperpolarized material in the aqueous
phase were described.
Figure 9. Schematic representation of biphasic SABRE catalysis.
8. Summary and Outlook
In summary, SABRE is a simple hyperpolarization
technique that brings together many different approaches of
magnetic resonance, synthetic chemistry and catalysis. There is
a need to understand all of these components if very high
polarization levels are to be achieved more generally. At the
heart of the SABRE process is the metal catalyst that mediates
polarization transfer and modifying the catalyst has caused
significant improvements in SABRE efficacy. This polarization
technique has been applied to a range of nuclei and has begun
to improve a number of analytical methods. The key
breakthrough for application of the SABRE technique in a clinical
setting will be the observation of a polarized substrate in vivo
and this could open the door to studying disease models in real
time.
Finally, whilst it is established that 1H and spin-½
heteronuclei can be readily sensitized by SABRE, the range of
molecules is limited by the necessity to bind to the metal center;
only aromatic heterocycles, nitriles, Schiff bases and diazirines
currently feature regularly. Thus, harnessing p-H2 more widely
will be the key to the future development of SABRE, particularly
with the proven use of pyruvate, glucose and urea in in vivo
DNP studies.
Overcoming the requirement for binding the target
substrate to the metal catalyst has recently been achieved using
a technique that has been named SABRE-RELAY.[75] This
method begins by using SABRE to hyperpolarize an amine or
ammonia and proton exchanges allows the relay of polarization
into the target substrate (Scheme 2). 1H NMR signal gains of up
to 650-fold per proton were reported in conjunction with 13C
signal enhancements at 9.4 T of 570-fold for 1-propanol.
Importantly, the simple polarization of 1H 13C, 31P and 15N nuclei
in a range of amide, alcohol, carboxylic acid, phosphate and
carbonate substrates was exemplified. Moreover, as this
methodology gives access to hyperpolarized pyruvate, glucose
and urea, with development it may ultimately reflect a cost
efficient alternative to DNP. We predict that the advent of
SABRE-RELAY will greatly increase the range of p-H2 based
hyperpolarization applications in the future and encourage a far
greater array of researchers to contribute to these developments.
MINIREVIEW
Scheme 2. Schematic representation for the SABRE-RELAY process in which
an amine or ammonia is polarized and then subsequently relays its
polarization to a target substrate (sub) via proton exchange.
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